-
1
-
-
84928926597
-
IgA vasculitis (Henoch-Shonlein purpura) in adults: diagnostic and therapeutic aspects
-
Audemard-Verger A, Pillebout E, Guillevin L et al. IgA vasculitis (Henoch-Shonlein purpura) in adults: diagnostic and therapeutic aspects. Autoimmun Rev 2015; 14: 579-585
-
(2015)
Autoimmun Rev
, vol.14
, pp. 579-585
-
-
Audemard-Verger, A1
Pillebout, E2
Guillevin, L3
-
2
-
-
0036232277
-
Henoch-Schonlein purpura in adults: outcome and prognostic factors
-
Pillebout E, Thervet E, Hill G et al. Henoch-Schonlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 2002; 13: 1271-1278
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 1271-1278
-
-
Pillebout, E1
Thervet, E2
Hill, G3
-
3
-
-
33947210018
-
Clinical update: Henoch-Schonlein purpura
-
Saulsbury FT. Clinical update: Henoch-Schonlein purpura. Lancet 2007; 369: 976-978
-
(2007)
Lancet
, vol.369
, pp. 976-978
-
-
Saulsbury, FT.1
-
4
-
-
0030684769
-
Long-term prognosis of Henoch-Schonlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schonlein purpura
-
Coppo R, Mazzucco G, Cagnoli L et al. Long-term prognosis of Henoch-Schonlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schonlein purpura. Nephrol Dial Transplant 1997; 12: 2277-2283
-
(1997)
Nephrol Dial Transplant
, vol.12
, pp. 2277-2283
-
-
Coppo, R1
Mazzucco, G2
Cagnoli, L3
-
5
-
-
84926252365
-
Henoch-Schonlein purpura nephritis in children
-
Davin JC, Coppo R. Henoch-Schonlein purpura nephritis in children. Nat Rev Nephrol 2014; 10: 563-573
-
(2014)
Nat Rev Nephrol
, vol.10
, pp. 563-573
-
-
Davin, JC1
Coppo, R.2
-
6
-
-
84870582400
-
Clinical outcomes, when matched at presentation, do not vary between adult-onset Henoch-Schonlein purpura nephritis and IgA nephropathy
-
Oh HJ, Ahn SV, Yoo DE et al. Clinical outcomes, when matched at presentation, do not vary between adult-onset Henoch-Schonlein purpura nephritis and IgA nephropathy. Kidney Int 2012; 82: 1304-1312
-
(2012)
Kidney Int
, vol.82
, pp. 1304-1312
-
-
Oh, HJ1
Ahn, SV2
Yoo, DE3
-
7
-
-
79958856066
-
Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schonlein purpura nephritis
-
Kiryluk K, Moldoveanu Z, Sanders JT et al. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schonlein purpura nephritis. Kidney Int 2011; 80: 79-87
-
(2011)
Kidney Int
, vol.80
, pp. 79-87
-
-
Kiryluk, K1
Moldoveanu, Z2
Sanders, JT3
-
8
-
-
0034608117
-
Fca receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice
-
Launay P, Grossetete B, Arcos-Fajardo M et al. Fca receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice. J Exp Med 2000; 191: 1999-2009
-
(2000)
J Exp Med
, vol.191
, pp. 1999-2009
-
-
Launay, P1
Grossetete, B2
Arcos-Fajardo, M3
-
9
-
-
84861756076
-
Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
-
Berthelot L, Papista C, Maciel TT et al. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med 2012; 209: 793-806
-
(2012)
J Exp Med
, vol.209
, pp. 793-806
-
-
Berthelot, L1
Papista, C2
Maciel, TT3
-
10
-
-
67651006853
-
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity
-
Suzuki H, Fan R, Zhang Z et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 2009; 119: 1668-1677
-
(2009)
J Clin Invest
, vol.119
, pp. 1668-1677
-
-
Suzuki, H1
Fan, R2
Zhang, Z3
-
11
-
-
78649659186
-
Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy
-
Vuong MT, Hahn-Zoric M, Lundberg S et al. Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy. Kidney Int 2010; 78: 1281-1287
-
(2010)
Kidney Int
, vol.78
, pp. 1281-1287
-
-
Vuong, MT1
Hahn-Zoric, M2
Lundberg, S3
-
12
-
-
84865976351
-
Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy
-
Berthoux F, Suzuki H, Thibaudin L et al. Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy. J Am Soc Nephrol 2012; 23: 1579-1587
-
(2012)
J Am Soc Nephrol
, vol.23
, pp. 1579-1587
-
-
Berthoux, F1
Suzuki, H2
Thibaudin, L3
-
13
-
-
84942982914
-
Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes
-
Berthelot L, Robert T, Vuiblet V et al. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes. Kidney Int 2015; 88: 815-822
-
(2015)
Kidney Int
, vol.88
, pp. 815-822
-
-
Berthelot, L1
Robert, T2
Vuiblet, V3
-
14
-
-
77951559626
-
EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria
-
Ozen S, Pistorio A, Iusan SM et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 2010; 69: 798-806
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 798-806
-
-
Ozen, S1
Pistorio, A2
Iusan, SM3
-
15
-
-
82455210822
-
Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases
-
Tissandie E, Morelle W, Berthelot L et al. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases. Kidney Int 2011; 80: 1352-1363
-
(2011)
Kidney Int
, vol.80
, pp. 1352-1363
-
-
Tissandie, E1
Morelle, W2
Berthelot, L3
-
16
-
-
78649477601
-
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
-
Pencina MJ, D'Agostino RB, Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011; 30: 11-21
-
(2011)
Stat Med
, vol.30
, pp. 11-21
-
-
Pencina, MJ1
D'Agostino, RB2
Steyerberg, EW.3
-
17
-
-
38849091997
-
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond
-
discussion 207-112
-
Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172; discussion 207-112.
-
(2008)
Stat Med
, vol.27
, pp. 157-172
-
-
Pencina, MJ1
D'Agostino, RB2
D'Agostino, RB3
-
18
-
-
0031925983
-
Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis
-
Allen AC, Willis FR, Beattie TJ et al. Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 1998; 13: 930-934
-
(1998)
Nephrol Dial Transplant
, vol.13
, pp. 930-934
-
-
Allen, AC1
Willis, FR2
Beattie, TJ3
-
19
-
-
84873035597
-
IgA nephropathy: molecular mechanisms of the disease
-
Mestecky J, Raska M, Julian BA et al. IgA nephropathy: molecular mechanisms of the disease. Annu Rev Pathol 2013; 8: 217-240
-
(2013)
Annu Rev Pathol
, vol.8
, pp. 217-240
-
-
Mestecky, J1
Raska, M2
Julian, BA3
-
20
-
-
84866376076
-
The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
-
Zhao N, Hou P, Lv J et al. The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression. Kidney Int 2012; 82: 790-796
-
(2012)
Kidney Int
, vol.82
, pp. 790-796
-
-
Zhao, N1
Hou, P2
Lv, J3
-
21
-
-
84901462125
-
A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases
-
Yanagawa H, Suzuki H, Suzuki Y et al. A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases. PLoS One 2014; 9: e98081
-
(2014)
PLoS One
, vol.9
, pp. e98081
-
-
Yanagawa, H1
Suzuki, H2
Suzuki, Y3
-
22
-
-
77956283584
-
Genetic risk factors in lupus nephritis and IgA nephropathy-no support of an overlap
-
Vuong MT, Gunnarsson I, Lundberg S et al. Genetic risk factors in lupus nephritis and IgA nephropathy-no support of an overlap. PLoS One 2010; 5: e10559
-
(2010)
PLoS One
, vol.5
, pp. e10559
-
-
Vuong, MT1
Gunnarsson, I2
Lundberg, S3
-
23
-
-
84942982914
-
Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes
-
Berthelot L, Robert T, Vuiblet V et al. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes. Kidney Int 2015; 88: 815-822
-
(2015)
Kidney Int
, vol.88
, pp. 815-822
-
-
Berthelot, L1
Robert, T2
Vuiblet, V3
-
24
-
-
84959325252
-
Urinary myeloid IgA Fc alpha receptor (CD89) and transglutaminase-2 as new biomarkers for active IgA nephropathy and Henoch-Schonlein purpura nephritis
-
Moresco RN, Speeckaert MM, Zmonarski SC et al. Urinary myeloid IgA Fc alpha receptor (CD89) and transglutaminase-2 as new biomarkers for active IgA nephropathy and Henoch-Schonlein purpura nephritis. BBA Clin 2016; 5: 79-84
-
(2016)
BBA Clin
, vol.5
, pp. 79-84
-
-
Moresco, RN1
Speeckaert, MM2
Zmonarski, SC3
-
25
-
-
84884857920
-
Raised serum levels of interleukins 6 and 8 and antiphospholipid antibodies in an adult patient with Henoch-Schonlein purpura
-
Kimura S, Takeuchi S, Soma Y et al. Raised serum levels of interleukins 6 and 8 and antiphospholipid antibodies in an adult patient with Henoch-Schonlein purpura. Clin Exp Dermatol 2013; 38: 730-736
-
(2013)
Clin Exp Dermatol
, vol.38
, pp. 730-736
-
-
Kimura, S1
Takeuchi, S2
Soma, Y3
-
26
-
-
33847694008
-
Thrombopoietin and interleukin-6 levels in Henoch-Schonlein purpura
-
Lin CY, Yang YH, Lee CC et al. Thrombopoietin and interleukin-6 levels in Henoch-Schonlein purpura. J Microbiol Immunol Infect 2006; 39: 476-482
-
(2006)
J Microbiol Immunol Infect
, vol.39
, pp. 476-482
-
-
Lin, CY1
Yang, YH2
Lee, CC3
-
27
-
-
84929399544
-
High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy
-
Rhee H, Shin N, Shin MJ et al. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy. Korean J Intern Med 2015; 30: 354-361
-
(2015)
Korean J Intern Med
, vol.30
, pp. 354-361
-
-
Rhee, H1
Shin, N2
Shin, MJ3
-
28
-
-
84929391665
-
Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy
-
Park GY, Yu CH, Kim JS et al. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy. Korean J Intern Med 2015; 30: 345-353
-
(2015)
Korean J Intern Med
, vol.30
, pp. 345-353
-
-
Park, GY1
Yu, CH2
Kim, JS3
-
29
-
-
84903529587
-
Elevated urinary levels of cystatin C and neutrophil gelatinase-associated lipocalin in Henoch-Schonlein purpura patients with renal involvement
-
Chen T, Lu YH, Wang WJ et al. Elevated urinary levels of cystatin C and neutrophil gelatinase-associated lipocalin in Henoch-Schonlein purpura patients with renal involvement. PLoS One 2014; 9: e101026
-
(2014)
PLoS One
, vol.9
, pp. e101026
-
-
Chen, T1
Lu, YH2
Wang, WJ3
-
30
-
-
84896889360
-
Renal neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 expression in children with acute kidney injury and Henoch-Schonlein purpura nephritis
-
Du Y, Hou L, Guo J et al. Renal neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 expression in children with acute kidney injury and Henoch-Schonlein purpura nephritis. Exp Ther Med 2014; 7: 1130-1134
-
(2014)
Exp Ther Med
, vol.7
, pp. 1130-1134
-
-
Du, Y1
Hou, L2
Guo, J3
|